Review of how cannabis affects the eyes: adverse effects and possible treatments
Cannabis causes several adverse eye effects including reduced corneal cell density, impaired night vision, and retinal dysfunction, while short-term intraocular pressure reduction is insufficient for glaucoma treatment.
Quick Facts
What This Study Found
Adverse ocular effects include eyelid tremor, ptosis, reduced corneal endothelial cell density, dry eyes, red eyes, and neuro-retinal dysfunction. Cannabis may transiently impair night vision, depth perception, and contrast sensitivity. THC reduces intraocular pressure short-term but insufficient for glaucoma. Potential therapeutic uses: treatment-refractory blepharospasm, dry eye, and MS-related nystagmus.
Key Numbers
Estimated 219 million cannabis users globally. THC reduces intraocular pressure transiently. Impairments documented in night vision, depth perception, binocular and monocular contrast sensitivity, and dynamic visual acuity.
How They Did This
Narrative review of current literature on adverse effects and therapeutic applications of cannabis and cannabinoids on the eye.
Why This Research Matters
Cannabis users should be aware of potential visual effects, and clinicians should not recommend cannabis for glaucoma despite its intraocular pressure-lowering effect. The review clarifies what is and is not supported by evidence for ocular conditions.
The Bigger Picture
The persistent myth that cannabis treats glaucoma originated from short-term IOP studies, but the effect is too brief and inconsistent for clinical use. This review helps update public understanding while identifying genuinely promising ocular applications.
What This Study Doesn't Tell Us
Narrative review without systematic methodology. Most ocular effects documented in case reports or small studies. Dose-response relationships poorly characterized. Chronic vs. acute use effects not always distinguished.
Questions This Raises
- ?Do corneal endothelial changes reverse after cannabis cessation?
- ?Could CBD-specific formulations provide ocular anti-inflammatory benefits without THC side effects?
Trust & Context
- Key Stat:
- IOP reduction too brief for glaucoma treatment
- Evidence Grade:
- Comprehensive narrative review covering diverse ocular effects, but based on heterogeneous and often small-scale evidence.
- Study Age:
- 2024 narrative review of cannabis and eye health literature
- Original Title:
- Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.
- Published In:
- Clinical ophthalmology (Auckland, N.Z.), 18, 3529-3556 (2024)
- Database ID:
- RTHC-05151
Evidence Hierarchy
Frequently Asked Questions
Can cannabis treat glaucoma?
No. While THC does temporarily lower intraocular pressure, the effect is too short-lived and inconsistent to be useful as a glaucoma treatment. Cannabis is not considered a first-line treatment for any eye condition.
Does cannabis affect vision?
Yes. Cannabis can transiently impair night vision, depth perception, contrast sensitivity, and dynamic visual acuity. Chronic use may reduce corneal endothelial cell density.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05151APA
Bondok, Mostafa; Nguyen, Anne Xuan-Lan; Lando, Leonardo; Wu, Albert Y. (2024). Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.. Clinical ophthalmology (Auckland, N.Z.), 18, 3529-3556. https://doi.org/10.2147/OPTH.S501494
MLA
Bondok, Mostafa, et al. "Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.." Clinical ophthalmology (Auckland, 2024. https://doi.org/10.2147/OPTH.S501494
RethinkTHC
RethinkTHC Research Database. "Adverse Ocular Impact and Emerging Therapeutic Potential of ..." RTHC-05151. Retrieved from https://rethinkthc.com/research/bondok-2024-adverse-ocular-impact-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.